These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25949829)

  • 21. Minimal changes with long-term administration of anxiolytics on septal driving of hippocampal rhythmical slow activity.
    Zhu XO; McNaughton N
    Psychopharmacology (Berl); 1995 Mar; 118(1):93-100. PubMed ID: 7597127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular correlates of hippocampal theta rhythm in identified pyramidal cells, granule cells, and basket cells.
    Ylinen A; Soltész I; Bragin A; Penttonen M; Sik A; Buzsáki G
    Hippocampus; 1995; 5(1):78-90. PubMed ID: 7787949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrinsic modulation of theta field activity in the entorhinal cortex of the anesthetized rat.
    Dickson CT; Trepel C; Bland BH
    Hippocampus; 1994 Feb; 4(1):37-51. PubMed ID: 8061751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat.
    Kinney GG; Patino P; Mermet-Bouvier Y; Starrett JE; Gribkoff VK
    J Pharmacol Exp Ther; 1999 Oct; 291(1):99-106. PubMed ID: 10490892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-hippocampal buspirone in animal models of anxiety.
    Kostowski W; Płaźnik A; Stefański R
    Eur J Pharmacol; 1989 Sep; 168(3):393-6. PubMed ID: 2573536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of halothane on type 2 immobility-related hippocampal theta field activity and theta-on/theta-off cell discharges.
    Bland BH; Bland CE; Colom LV; Roth SH; DeClerk S; Dypvik A; Bird J; Deliyannides A
    Hippocampus; 2003; 13(1):38-47. PubMed ID: 12625455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence.
    Engin E; Stellbrink J; Treit D; Dickson CT
    Neuroscience; 2008 Dec; 157(3):666-76. PubMed ID: 18940236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of buspirone on the behaviour of control and stressed mice.
    Pokk P; Zharkovsky A
    J Physiol Pharmacol; 1998 Mar; 49(1):175-85. PubMed ID: 9594420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?
    McNaughton N; Kocsis B; Hajós M
    Behav Pharmacol; 2007 Sep; 18(5-6):329-46. PubMed ID: 17762505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lateral septum as a regulator of hippocampal theta oscillations and defensive behavior in rats.
    Chee SS; Menard JL; Dringenberg HC
    J Neurophysiol; 2015 Mar; 113(6):1831-41. PubMed ID: 25589592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of perforant path procaine on hippocampal type 2 rhythmical slow-wave activity (theta) in the urethane-anesthetized rat.
    Heynen AJ; Bilkey DK
    Hippocampus; 1994 Dec; 4(6):683-95. PubMed ID: 7704111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA-A receptor modulators alter emotionality and hippocampal theta rhythm in an animal model of long-lasting anxiety.
    Hoeller AA; Duzzioni M; Duarte FS; Leme LR; Costa AP; Santos EC; de Pieri CH; dos Santos AA; Naime AA; Farina M; de Lima TC
    Brain Res; 2013 Sep; 1532():21-31. PubMed ID: 23911836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
    Peng WH; Wu CR; Chen CS; Chen CF; Leu ZC; Hsieh MT
    Life Sci; 2004 Oct; 75(20):2451-62. PubMed ID: 15350820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.
    Majercsik E; Haller J; Leveleki C; Baranyi J; Halász J; Rodgers RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Dec; 27(8):1187-99. PubMed ID: 14659474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Housing conditions and the anxiolytic efficacy of buspirone: the relationship between main and side effects.
    Haller J; Halász J; Makara GB
    Behav Pharmacol; 2000 Aug; 11(5):403-12. PubMed ID: 11103892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in hippocampal excitatory synaptic transmission during cholinergically induced theta and slow oscillation states.
    Schall KP; Dickson CT
    Hippocampus; 2010 Feb; 20(2):279-92. PubMed ID: 19437417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity.
    Mizuki Y; Suetsugi M; Ushijima I; Yamada M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):291-300. PubMed ID: 7519702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation.
    Siok CJ; Taylor CP; Hajós M
    Neuropharmacology; 2009 Feb; 56(2):379-85. PubMed ID: 18930748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Median raphe stimulation-induced motor inhibition concurrent with suppression of type 1 and type 2 hippocampal theta.
    Bland BH; Bland CE; MacIver MB
    Hippocampus; 2016 Mar; 26(3):289-300. PubMed ID: 26314691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.